Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome

Nitric Oxide - Biology and Chemistry

Volumn 24, Issue 4, 2011, Pages 224-228

  Palomo, Iván ^a   Contreras, Alejandra ^a   Alarcón, L Marcelo ^a   Leiva, Elba ^a   Guzmán, Luis ^a   Mujica, Verónica ^a   Icaza, Gloria ^a   Díaz, Nora ^a   González, Daniel R ^a   Moore Carrasco, Rodrigo ^a  

^a UNIVERSIDAD DE TALCA   (Chile)

Author keywords

Asymmetric dimethyl arginine; Endothelial dysfunction; Insulin resistance; Metabolic syndrome; Nitric oxide inhibitor; Oxidative stress

Indexed keywords

CD40 LIGAND; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MALONALDEHYDE; N(G),N(G) DIMETHYLARGININE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; URIC ACID; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD LEVEL; CHILE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOCRINE FUNCTION; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ARGININE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILE; CHOLESTEROL, LDL; FEMALE; HUMANS; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULAR CELL ADHESION MOLECULE-1; WAIST CIRCUMFERENCE;

EID: 79956371796     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2011.03.002     Document Type: Article

References (35)

1. J.P. Despres, I. Lemieux, Abdominal obesity and metabolic syndrome, Nature 444 (2006) 881-887. (Pubitemid 46024995)
2. K. Tziomalos, V.G. Athyros, A. Karagiannis, D.P. Mikhailidis, Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management, Nutr. Metab. Cardiovasc. Dis. 20 (2010) 140-146.
3. C. Napoli, N.F de, S. Williams-Ignarro, O. Pignalosa, V. Sica, L.J. Ignarro, Nitric oxide and atherosclerosis: an update, Nitric Oxide 15 (2006) 265-279. (Pubitemid 44649284)
4. I.H. Schulman, M.S. Zhou, Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases, Curr. Hypertens. Rep. 11 (2009) 48-55.
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation 106 (2002) 3143-3421.
6. N.N. Chan, J.C. Chan, Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?, Diabetologia 45 (2002) 1609-1616 (Pubitemid 35478130)
7. R.H. Boger, The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor, Cardiovasc. Res. 59 (2003) 824-833.
8. V.Achan,M.Broadhead,M.Malaki, G.Whitley, J. Leiper,R.MacAllister, P.Vallance, Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase, Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1455-1459.
9. J.T. Kielstein, B. Impraim, S. Simmel, S.M. Bode-Boger, D. Tsikas, J.C. Frolich, M.M. Hoeper, H. Haller, D. Fliser, Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans, Circulation 109 (2004) 172-177. (Pubitemid 38114135)
10. R.H. Boger, S.M. Bode-Boger, P.S. Tsao, P.S. Lin, J.R. Chan, J.P. Cooke, An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes, J. Am. Coll. Cardiol. 36 (2000) 2287-2295.
11. J.R. Chan, R.H. Boger, S.M. Bode-Boger, O. Tangphao, P.S. Tsao, T.F. Blaschke, J.P. Cooke, Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans, Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1040-1046. (Pubitemid 30207579)
12. R.H. Boger, L.M. Sullivan, E. Schwedhelm, T.J. Wang, R. Maas, E.J. Benjamin, F. Schulze, V. Xanthakis, R.A. Benndorf, R.S. Vasan, Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community, Circulation 119 (2009) 1592-1600.
13. R. Maas, F. Schulze, J. Baumert, H. Lowel, K. Hamraz, E. Schwedhelm, W. Koenig, R.H. Boger, Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data, Clin. Chem. 53 (2007) 693-701. (Pubitemid 46580240)
14. V.P. Valkonen, H. Paiva, J.T. Salonen, T.A. Lakka, T. Lehtimaki, J. Laakso, R. Laaksonen, Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine, Lancet 358 (2001) 2127-2128. (Pubitemid 34094905)
15. T. Leong, D. Zylberstein, I. Graham, L. Lissner, D. Ward, J. Fogarty, C. Bengtsson, C. Bjorkelund, D. Thelle, Asymmetric dimethylarginine independently predicts fatal, nonfatal myocardial infarction, stroke in women 24-year follow-up of the population study of women in Gothenburg, Arterioscler. Thromb. Vasc. Biol. 28 (2008) 961-967.
16. V. Mujica, E. Leiva, G. Icaza, N. Diaz, M. Arredondo, R. Moore-Carrasco, R. Orrego, M. Vasquez, I. Palomo, Evaluation of metabolic syndrome in adults of Talca city, Chile, Nutr. J. 7 (2008) 14.
17. I. Palomo, J. Jaramillo, M. Alarcon, C. Gutierrez, R. Moore-Carrasco, F. Segovia, E. Leiva, V. Mujica, G. Icaza, N. Diaz, Increased concentrations of soluble vascular cell adhesion molecule-1 and soluble CD40L in subjects with metabolic syndrome, Mol. Med. Rep. 2 (2010) 481-485.
18. G.I. Palomo, N.G. Icaza, E.V. Mujica, F.L. Nunez, M.E. Leiva, R.M. Vasquez, L.M. Alarcon, D.E. Moyano, Prevalence of cardiovascular risk factors in adult from Talca, Chile, Rev. Med. Chil. 135 (2007) 904-912.
19. J.E. Shaw, P.Z. Zimmet, K.G. Alberti, Point: impaired fasting glucose: the case for the new American Diabetes Association criterion, Diabetes Care 29 (2006) 1170-1172. (Pubitemid 44115266)
20. W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin. Chem. 18 (1972) 499-502.
21. H. Ohkawa, N. Ohishi, K. Yagi, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal. Biochem. 95 (1979) 351-358.
22. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia 28 (1985) 412-419. (Pubitemid 15018832)
23. H.M. Eid, H. Arnesen, E.M. Hjerkinn, T. Lyberg, I. Seljeflot, Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, Metabolism 53 (2004) 1574-1579.
24. K. Krzyzanowska, F. Mittermayer, H.P. Kopp, M. Wolzt, G. Schernthaner, Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women, J. Clin. Endocrinol. Metab. 89 (2004) 6277-6281. (Pubitemid 39628445)
25. T. McLaughlin, M. Stuhlinger, C. Lamendola, F. Abbasi, J. Bialek, G.M. Reaven, P.S. Tsao, Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss, J. Clin. Endocrinol. Metab. 91 (2006) 1896-1900.
26. B. Spoto, R.M. Parlongo, G. Parlongo, E. Sgro', C. Zoccali, The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes, J. Nephrol. 20 (2007) 554-559.
27. J.A. Chirinos, R. David, J.A. Bralley, H. Zea-Diaz, E. Munoz-Atahualpa, F. Corrales-Medina, C. Cuba-Bustinza, J. Chirinos-Pacheco, J. Medina-Lezama, Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study, Hypertension 52 (2008) 1051-1059.
28. D. Wang, S. Strandgaard, J. Iversen, C.S. Wilcox, Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension, Am. J. Physiol. Regul. Integr. Comp. Physiol. 296 (2009) R195-R200.
29. P. Vallance, J. Leiper, Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway, Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1023-1030. (Pubitemid 38737826)
30. R.H. Boger, K. Sydow, J. Borlak, T. Thum, H. Lenzen, B. Schubert, D. Tsikas, S.M. Bode-Boger, LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S- adenosylmethionine-dependentmethyltransferases, Circ. Res. 87 (2000) 99-105.
31. J. Leiper, M. Nandi, B. Torondel, J. Murray-Rust, M. Malaki, B. O'Hara, S. Rossiter, S. Anthony, M. Madhani, D. Selwood, C. Smith, B. Wojciak-Stothard, A. Rudiger, R. Stidwill, N.Q. McDonald, P. Vallance, Disruption of methylarginine metabolism impairs vascular homeostasis, Nat. Med. 13 (2007) 198-203.
32. I. Palomo, J. Herrera, V. Cancino, M. Alarcon, V. Mujica, E. Leiva, N. Diaz, G. Icaza, A. Urzua, M. Vazquez, D.R. Gonzalez, R. Moore-Carrasco, Physical activity reduces circulating TNF-alpha but not pro-thrombotic factors levels in patients with metabolic syndrome, Diabetes Metab. Synd.: Clin. Res. Rev. 4 (2010) 234-238.
33. E. Monsalve, P.J. Oviedo, M.A. Garcia-Perez, J.J. Tarin, A. Cano, C. Hermenegildo, Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells, Cardiovasc. Res. 73 (2007) 66-72.
34. V.A. Gomes, A. Casella-Filho, A.C. Chagas, J.E. Tanus-Santos, Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome, Nitric Oxide Biol. Chem. 19 (2008) 345-350.
35. E.B. Marliss, S. Chevalier, R. Gougeon, J.A. Morais, M. Lamarche, O.A. Adegoke, G. Wu, Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover, Diabetologia 49 (2006) 351-359. (Pubitemid 43185404)